March 2, 2026 · Form 4 insider transaction
Salus Thomas D. bought 30,000 shares of LFCR, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.; Restricted Stock Units will vest on the 3rd anniversary of the grant date.